These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 12792702)

  • 1. The effects of 2,3-diphosphoglycerate, adenosine triphosphate, and glycosylated hemoglobin on the hemoglobin-oxygen affinity of diabetic patients.
    Castilho EM; Glass ML; Manço JC
    Braz J Med Biol Res; 2003 Jun; 36(6):731-7. PubMed ID: 12792702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Left ventricular function in insulin-dependent and in non-insulin-dependent diabetic patients: radionuclide assessment.
    Astorri E; Fiorina P; Gavaruzzi G; Astorri A; Magnati G
    Cardiology; 1997; 88(2):152-5. PubMed ID: 9096915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors related to glycemic control in IDDM and insulin-treated NIDDM patients in current practice. A comparison of care policies. SIEMTIC Group. Studio Italiano Epidemiologico Multicentrico su Terapia Insulin e Controllo Metabolico.
    Garancini MP; Gallus G; Cucinotta D; Rossi A; Riccardi G
    Diabetes Care; 1997 Nov; 20(11):1659-63. PubMed ID: 9353604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenosine triphosphate release by osmotic shock and hemoglobin A1C in diabetic subjects' erythrocytes.
    Petruzzi E; Orlando C; Pinzani P; Sestini R; Del Rosso A; Dini G; Tanganelli E; Buggiani A; Pazzagli M
    Metabolism; 1994 Apr; 43(4):435-40. PubMed ID: 8159099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxygen release kinetics in healthy subjects and diabetic patients. I: The role of 2,3-diphosphoglycerate.
    Marschner JP; Rietbrock N
    Int J Clin Pharmacol Ther; 1994 Oct; 32(10):533-5. PubMed ID: 7834160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxygen transport impairment in diabetes.
    Ditzel J
    Diabetes; 1976; 25(2 SUPPL):832-8. PubMed ID: 9322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of insulin lispro in combination with NPH human insulin twice per day in patients with insulin-dependent or non-insulin-dependent diabetes mellitus. Multicenter Insulin Lispro Study Group.
    Vignati L; Anderson JH; Iversen PW
    Clin Ther; 1997; 19(6):1408-21. PubMed ID: 9444449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Serum osteocalcin and diabetes mellitus. A study of 98 patients].
    Cantini F; Arcangeli A; Bellandi F; Pedone T; Villani G; Ponzio A; Palchetti R
    Minerva Med; 1992 Mar; 83(3):129-33. PubMed ID: 1553061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exogenous insulin administration and cardiovascular risk in non-insulin-dependent and insulin-dependent diabetes mellitus.
    Genuth S
    Ann Intern Med; 1996 Jan; 124(1 Pt 2):104-9. PubMed ID: 8554200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [2,3-diphosphoglycerate and glycosylated hemoglobin in diabetes mellitus].
    Stufano N; Altomare E; Conese A; Sabbà C; Carbone P; Vendemiale G; Palasciano G; Albano O
    Boll Soc Ital Biol Sper; 1983 Dec; 59(12):1849-54. PubMed ID: 6671045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of BMI, insulin dose and number of injections on glycaemic control in insulin-using diabetic patients. Studygroup Diabetes Rijnmond (SDR).
    Jacobs ML; Elte JW; van Ouwerkerk BM; Janssens EN; Schop C; Knoop JA; Hoogma RP; Groenendijk R; Weber RF
    Neth J Med; 1997 Apr; 50(4):153-9. PubMed ID: 9130838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of intensive treatment of diabetes of the risk of death or renal failure in NIDDM and IDDM.
    Hellman R; Regan J; Rosen H
    Diabetes Care; 1997 Mar; 20(3):258-64. PubMed ID: 9051368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective determination of non-enzymatic glycosylated serum albumin as a medium term index of diabetic control.
    Wörner W; Pfleiderer S; Rietbrock N
    Int J Clin Pharmacol Ther Toxicol; 1993 May; 31(5):218-22. PubMed ID: 8314651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased complications in noninsulin-dependent diabetic patients treated with insulin versus oral hypoglycemic agents: a population study.
    Savage S; Estacio RO; Jeffers B; Schrier RW
    Proc Assoc Am Physicians; 1997 Mar; 109(2):181-9. PubMed ID: 9069587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of insulin on body composition in patients with insulin-dependent and non-insulin-dependent diabetes.
    Sinha A; Formica C; Tsalamandris C; Panagiotopoulos S; Hendrich E; DeLuise M; Seeman E; Jerums G
    Diabet Med; 1996 Jan; 13(1):40-6. PubMed ID: 8741811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidative stress parameters in type I, type II and insulin-treated type 2 diabetes mellitus; insulin treatment efficiency.
    Seghrouchni I; Drai J; Bannier E; Rivière J; Calmard P; Garcia I; Orgiazzi J; Revol A
    Clin Chim Acta; 2002 Jul; 321(1-2):89-96. PubMed ID: 12031597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of insulin-dependent diabetes mellitus in patients undergoing carotid endarterectomy.
    Pothof AB; O'Donnell TFX; Swerdlow NJ; Liang P; Li C; Varkevisser RRB; de Borst GJ; Schermerhorn ML
    J Vasc Surg; 2019 Mar; 69(3):814-823. PubMed ID: 30714571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of 2,3-diphosphoglycerate on O2-dissociation kinetics of hemoglobin and glycosylated hemoglobin using the stopped flow technique and an improved in vitro method for hemoglobin glycosylation.
    Marschner JP; Seidlitz T; Rietbrock N
    Int J Clin Pharmacol Ther; 1994 Mar; 32(3):116-21. PubMed ID: 8205371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycemic control in diabetes mellitus: have changes in therapy made a difference?
    Nathan DM; McKitrick C; Larkin M; Schaffran R; Singer DE
    Am J Med; 1996 Feb; 100(2):157-63. PubMed ID: 8629649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Previous episodes of hypoglycemic coma are not associated with permanent cognitive brain dysfunction in IDDM patients on intensive insulin treatment.
    Kramer L; Fasching P; Madl C; Schneider B; Damjancic P; Waldhäusl W; Irsigler K; Grimm G
    Diabetes; 1998 Dec; 47(12):1909-14. PubMed ID: 9836523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.